Home > GAMMAGARD Products > GAMMAGARD LIQUID IV > Protection

Protection
GAMMAGARD LIQUID - IV Administration

Protecting life’s moments with sustained protection against infection1,2

In the IV administration of GAMMAGARD LIQUID clinical study:

validated acute serious bacterial infections

Summary of Validated Acute Serious Bacterial Infections for the Per-Protocol Analysis

 

P valueb P < .0001 | 95% confidence interval (0.000, 0.064)

aSerious acute bacterial infections were defined by FDA and met specific diagnostic requirements.

bThe rate of validated infections was compared with a rate of <1 per subject per year, in accordance with recommendations by the FDA Blood Products Advisory Committee.

hospitalizations secondary to validated bacterial infections
 
validated other bacterial infections
 

Summary of Validated Other Bacterial Infections

cThe rate of validated infections was compared with a rate of <1 per subject per year, in accordance with recommendations by the FDA Blood Products Advisory Committee.

dOther bacterial infections that met specific diagnostic requirements.

References: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information]. Westlake Village, CA: Baxter Healthcare Corporation. April 2014. 2. Church JA, Leibl H, Stein MR, et al, and the US-PID-IGIV 10%-Study Group. Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IVIG 10%] in patients with primary immunodeficiency. J Clin Immunol. 2006;26:388-395.


  • Your patients can get access to experienced Patient and Nurse Advocates, insurance and financial support, useful tools, and more.
    Find Out How
  • Infusion Training Get training support from our Nurse
    Advocates on intravenous and subcutaneous administration of GAMMAGARD LIQUID.

    Call 1-855-250-5111 to talk to a
    Nurse Advocate
  • Insurance Assistance For access to experts who can provide expedited benefits verification and other insurance coverage resources, call 1-855-250-5111.
  • Choosing IV or SC Which is the right choice for your patient? Compare the differences using our chart.
    Take a Look

You are now leaving GAMMAGARD.com

Shire is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the GAMMAGARD.com site. A link to other web sites does not constitute an endorsement of Shire of the linked site, its products or services.

The browser window or tab for GAMMAGARD.com will remain open underneath the new browser window or tab. To return to GAMMAGARD.com at any time, close this tab or window.

Return to
GAMMAGARD.com
Continue